Cargando…

P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma

Prolyl 4-hydroxylase, beta polypeptide (P4HB) protein is an endoplasmic reticulum (ER) molecular chaperone protein and has been reported to be overexpressed in multiple tumor types. However, the role of P4HB in bladder cancer (BLCA) has not yet been elucidated. The aim of the present study was to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yucai, Peng, Yiji, Guan, Bao, He, Anbang, Yang, Kunlin, He, Shiming, Gong, Yanqing, Li, Xuesong, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751343/ https://www.ncbi.nlm.nih.gov/pubmed/33376528 http://dx.doi.org/10.3892/ol.2020.12356

Ejemplares similares

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2
por: Zhan, Yonghao, et al.
Publicado: (2017)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
por: Chen, Zhicong, et al.
Publicado: (2019)

Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2018)

Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2023)

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome
por: Guan, Bao, et al.
Publicado: (2022)

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center
por: Li, Yifan, et al.
Publicado: (2019)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2023)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2020)

Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2023)

ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers
por: He, Anbang, et al.
Publicado: (2018)

Comprehensive analysis of m6A regulators prognostic value in prostate cancer
por: Ji, Guangjie, et al.
Publicado: (2020)

Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2021)

Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer
por: Zhang, Cuijian, et al.
Publicado: (2021)

Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
por: Peng, Ding, et al.
Publicado: (2018)

Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma
por: Peng, Ding, et al.
Publicado: (2022)

AB169. CCDC34 is up-regulated in bladder cancer and its silencing suppresses bladder cancer cell proliferation and migration
por: Gong, Yanqing, et al.
Publicado: (2015)

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma
por: Xiong, Gengyan, et al.
Publicado: (2015)

Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022)

Terminal augmented ureteroplasty with bladder onlay flap technique for recurrent distal ureteral stricture after ureteroneocystostomy: an initial case series
por: Wu, Yucai, et al.
Publicado: (2021)

Upregulation of ATP Binding Cassette Subfamily C Member 5 facilitates Prostate Cancer progression and Enzalutamide resistance via the CDK1-mediated AR Ser81 Phosphorylation Pathway
por: Ji, Guangjie, et al.
Publicado: (2021)

AB015. The expression and function of coiled-coil domain-containing protein 34 in human bladder carcinoma
por: Gong, Yanqing, et al.
Publicado: (2016)

Construction of diagnostic and subtyping models for renal cell carcinoma by genome-wide DNA methylation profiles
por: Zhang, Jianye, et al.
Publicado: (2021)

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
por: Li, Yifan, et al.
Publicado: (2018)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer
por: Huang, Cong, et al.
Publicado: (2023)

Fluoroscopy-free minimally invasive ureteral stricture balloon dilatation: a retrospective safety and efficacy cohort study
por: Peng, Yiji, et al.
Publicado: (2021)

Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis
por: Chen, Zhicong, et al.
Publicado: (2018)

Significant Prognostic Value of the Autophagy-Related Gene P4HB in Bladder Urothelial Carcinoma
por: Lyu, Lei, et al.
Publicado: (2020)

Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma
por: Bao, Zhengqing, et al.
Publicado: (2019)

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy
por: Huang, Cong, et al.
Publicado: (2023)

Single‐Cell RNA‐seq Reveals a Developmental Hierarchy Super‐Imposed Over Subclonal Evolution in the Cellular Ecosystem of Prostate Cancer
por: Ge, Guangzhe, et al.
Publicado: (2022)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e44tlm8d6mbk8m1tg6bgqhhi34